Zhenlin Yang

Fudan University

H指数:17

被引数:2,971

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Therapeutic antibodies targeting G protein-coupled receptors

靶向G蛋白偶联受体的治疗性抗体

Trends in Pharmacological Sciences

IF19.9

2026-01-070

PRE

NIR Ratiometric Fluorescent Antibody-Drug Conjugate for Metastatic Ovarian Cancer Theranostics and Treatment Response Monitoring

NIR比率荧光抗体-药物偶联物在转移性卵巢癌诊疗及治疗反应监测中的应用

ADVANCED SCIENCE

IF14.1

2025-11-010

OAAI

A synergistic generative-ranking framework for tailored design of therapeutic single-domain antibodies

一种用于定制化设计治疗性单域抗体的协同生成-排序框架

Cell Discovery

IF12.5

2025-10-290

Oral Administration of Trifluoroacetyl Chitosan-Encapsulated Redshifted Immunofluorophore for NIR-II Bioimaging of Colorectal Metastases

经口给予三氟乙酸壳聚糖包封的红移免疫荧光探针用于结肠癌转移的NIR-II生物成像

ADVANCED HEALTHCARE MATERIALS

IF9.6

2025-10-010

PRE

Engineering a novel light-chain single-domain antibody to enable IgG-format bispecific antibody design

设计一种新型的轻链单域抗体，以实现IgG型双特异性抗体的设计

Antibody Therapeutics

IF4.5

2025-10-010

PRE

An IL-15-modified NKp30×HER2 trispecific NK cell engager enhances NK cell activation and tumor cell killing

IL-15修饰的NKp30×HER2三特异性NK细胞结合剂增强了NK细胞的活化和肿瘤细胞杀伤。

Journal of Leukocyte Biology

IF3.1

2025-07-220

PRE

Fully human single-domain antibody targeting a highly conserved cryptic epitope on the Nipah virus G protein

NATURE COMMUNICATIONS

IF15.7

2024-08-120

OAAI

Evaluation of vaccine effectiveness against SARS-CoV-2 variants by serological epitope profiling

CLINICAL AND TRANSLATIONAL MEDICINE

IF6.8

2023-01-180

OAAI

Inhalable antibodies for the treatment of COVID-19

INNOVATION

IF25.7

2022-11-018

OAAI

ADVANCED HEALTHCARE MATERIALS

IF9.6

2022-09-131

PRE

A highly stable human single-domain antibody-drug conjugate exhibits superior penetration and treatment of solid tumors

高度稳定的人单域抗体-药物缀合物表现出优异的渗透性和对实体瘤的治疗

MOLECULAR THERAPY

IF12

2022-08-0133

OAAI

An antigen-strengthened dye-modified fully-human-nanobody-based immunoprobe for second near infrared bioimaging of metastatic tumors

BIOMATERIALS

IF12.9

2022-08-014

PRE

Crystal structure of ISG54 reveals a novel RNA binding structure and potential functional mechanisms (vol 0, 1, 2022)

CELL RESEARCH

IF25.9

2022-05-181

The prominent role of a CDR1 somatic hypermutation for convergent IGHV3-53/3-66 antibodies in binding to SARS-CoV-2

EMERGING MICROBES & INFECTIONS

IF7.5

2022-04-256

OAAI

Covalently Engineered Protein Minibinders with Enhanced Neutralization Efficacy against Escaping SARS-CoV-2 Variants

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

IF15.6

2022-02-2532

PRE

Real-time digital polymerase chain reaction (PCR) as a novel technology improves limit of detection for rare allele assays

TRANSLATIONAL LUNG CANCER RESEARCH

IF3.5

2021-12-015

OAAI

Structures of the human cholecystokinin receptors bound to agonists and antagonists

NATURE CHEMICAL BIOLOGY

IF13.7

2021-09-2338

PREAI

A novel and effective approach to generate germline-like monoclonal antibodies by integration of phage and mammalian cell display platforms

通过整合噬菌体和哺乳动物细胞展示平台产生种系样单克隆抗体的新方法

ACTA PHARMACOLOGICA SINICA

IF8.4

2021-07-079

OAAI

Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody

传染性非典型肺炎冠状病毒特异性人单克隆抗体对2019新型冠状病毒刺突蛋白的有效结合

EMERGING MICROBES & INFECTIONS

IF7.5

2020-02-17708

OAAI

Drosophila YBX1 homolog YPS promotes ovarian germ line stem cell development by preferentially recognizing 5-methylcytosine RNAs

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2020-02-0375

OAAI

Zhenlin Yang

个人简介

教育背景

工作经历

荣誉奖项

研究方向